10-Q Filing

AIM IMMUNOTECH INC. CIK: 946644 Q3 2016

Filing Information

Form Type	10-Q
Accession Number	`0001615774-16-008259`
Period End Date	20160930
Filing Date	20161114
Fiscal Year	2016
Fiscal Period	Q3
XBRL Instance	heb-20160930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 65 Income Statement 76 Cash Flow Statement 63 Stockholders Equity 13

Balance Sheet 65 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.47M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.12M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.16M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.16M	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesCurrent`	$6.79M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesCurrent`	$3.54M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventory-work in process	`InventoryWorkInProcess`	-	USD	Point-in-time
Inventory-work in process	`InventoryWorkInProcess`	-	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory-work in process	`InventoryWorkInProcess`	$1.33M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	$764.00K	USD	Point-in-time
Assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	-	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$559.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$335.00K	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	20.63M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	24.11M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	24.11M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$10.57M	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	20.63M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$9.33M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$11.24M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$9.78M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$919.00K	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$862.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.55M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$134.00K	USD	Point-in-time
Total assets	`Assets`	$22.80M	USD	Point-in-time
Total assets	`Assets`	$21.58M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.21M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.01M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.42M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.22M	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	-	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	$1.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.43M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.43M	USD	Point-in-time
Redeemable warrants	`RedeemableWarrants`	$2.51M	USD	Point-in-time
Redeemable warrants	`RedeemableWarrants`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 24,105,569 and 20,629,957, respectively	`CommonStockValue`	$21.00K	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 24,105,569 and 20,629,957, respectively	`CommonStockValue`	$24.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$313.45M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$315.86M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$71.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-97.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-293.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-299.33M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$20.37M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$16.63M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$22.80M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$21.58M	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Clinical treatment programs	`HealthCareOrganizationRevenue`	$106.00K	USD	3 Qtrs
Clinical treatment programs	`HealthCareOrganizationRevenue`	$23.00K	USD	1 Quarter
Clinical treatment programs	`HealthCareOrganizationRevenue`	$22.00K	USD	1 Quarter
Clinical treatment programs	`HealthCareOrganizationRevenue`	$76.00K	USD	3 Qtrs
Total revenues	`SalesRevenueNet`	$23.00K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$106.00K	USD	3 Qtrs
Total revenues	`SalesRevenueNet`	$76.00K	USD	3 Qtrs
Total revenues	`SalesRevenueNet`	$22.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	$272.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	$353.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	$1.23M	USD	3 Qtrs
Production costs	`ManufacturingCosts`	$830.00K	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$3.24M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.34M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$7.08M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.97M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$5.60M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.69M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.63M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$5.72M	USD	3 Qtrs
Total costs and expenses	`CostsAndExpenses`	$13.91M	USD	3 Qtrs
Total costs and expenses	`CostsAndExpenses`	$4.01M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$9.79M	USD	3 Qtrs
Total costs and expenses	`CostsAndExpenses`	$3.25M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-3.98M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-9.72M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-3.23M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-13.81M	USD	3 Qtrs
Interest expense	`InterestExpense`	-	USD	3 Qtrs
Interest expense	`InterestExpense`	$1.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$3.00K	USD	3 Qtrs
Interest expense	`InterestExpense`	-	USD	1 Quarter
Interest and other income/(expense)	`InterestAndOtherIncome`	$156.00K	USD	3 Qtrs
Interest and other income/(expense)	`InterestAndOtherIncome`	$343.00K	USD	3 Qtrs
Interest and other income/(expense)	`InterestAndOtherIncome`	$181.00K	USD	1 Quarter
Interest and other income/(expense)	`InterestAndOtherIncome`	$40.00K	USD	1 Quarter
Insurance proceeds from legal settlement, net	`ProceedsFromInsuranceSettlementInvestingActivities`	-	USD	1 Quarter
Insurance proceeds from legal settlement, net	`ProceedsFromInsuranceSettlementInvestingActivities`	-	USD	3 Qtrs
Insurance proceeds from legal settlement, net	`ProceedsFromInsuranceSettlementInvestingActivities`	$-1.63M	USD	3 Qtrs
Insurance proceeds from legal settlement, net	`ProceedsFromInsuranceSettlementInvestingActivities`	$-190.00K	USD	1 Quarter
Gain (Loss) on sales of short term marketable securities	`MarketableSecuritiesGainLoss`	-	USD	1 Quarter
Gain (Loss) on sales of short term marketable securities	`MarketableSecuritiesGainLoss`	$31.00K	USD	1 Quarter
Gain (Loss) on sales of short term marketable securities	`MarketableSecuritiesGainLoss`	-	USD	3 Qtrs
Gain (Loss) on sales of short term marketable securities	`MarketableSecuritiesGainLoss`	$-56.00K	USD	3 Qtrs
Gain from sale of income tax net operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	$-1.56M	USD	3 Qtrs
Gain from sale of income tax net operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	$-1.37M	USD	3 Qtrs
Gain from sale of income tax net operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	-	USD	1 Quarter
Gain from sale of income tax net operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	-	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-103.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	3 Qtrs
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-103.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-6.33M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.80M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-12.09M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.86M	USD	1 Quarter
Reclassification adjustments for (gain) loss on sales of short term marketable securities included in net loss	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$56.00K	USD	3 Qtrs
Reclassification adjustments for (gain) loss on sales of short term marketable securities included in net loss	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	1 Quarter
Reclassification adjustments for (gain) loss on sales of short term marketable securities included in net loss	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-31.00K	USD	1 Quarter
Reclassification adjustments for (gain) loss on sales of short term marketable securities included in net loss	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	3 Qtrs
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-241.00K	USD	3 Qtrs
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$112.00K	USD	3 Qtrs
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$15.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-215.00K	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-12.33M	USD	3 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-6.16M	USD	3 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-2.88M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-4.02M	USD	1 Quarter
Basic and diluted loss per share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.30	USD	3 Qtrs
Basic and diluted loss per share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.13	USD	1 Quarter
Basic and diluted loss per share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.18	USD	1 Quarter
Basic and diluted loss per share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.62	USD	3 Qtrs
Weighted average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	21.83M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	21.05M	shares	3 Qtrs
Weighted average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	20.56M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	19.36M	shares	3 Qtrs

Cash Flow Statement 63 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-6.33M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.80M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-12.09M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.86M	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$663.00K	USD	3 Qtrs
Depreciation of property and equipment	`Depreciation`	$854.00K	USD	3 Qtrs
Amortization and abandonment of patent and trademark rights	`AmortizationAndAbandonmentOfIntagibleAssets`	$166.00K	USD	3 Qtrs
Amortization and abandonment of patent and trademark rights	`AmortizationAndAbandonmentOfIntagibleAssets`	$125.00K	USD	3 Qtrs
Equity-based compensation	`StockOptionPlanExpense`	$148.00K	USD	3 Qtrs
Equity-based compensation	`StockOptionPlanExpense`	$344.00K	USD	3 Qtrs
Realized loss on sale of marketable securities	`MarketableSecuritiesRealizedGainLoss`	-	USD	3 Qtrs
Realized loss on sale of marketable securities	`MarketableSecuritiesRealizedGainLoss`	$-56.00K	USD	3 Qtrs
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-103.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	3 Qtrs
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-103.00K	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	-	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$1.33M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$224.00K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-121.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-202.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$97.00K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$201.00K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-515.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-12.74M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-5.28M	USD	3 Qtrs
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$226.00K	USD	3 Qtrs
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$160.00K	USD	3 Qtrs
Additions to patent, trademark and licensing rights	`PaymentsToAcquireIntangibleAssets`	$282.00K	USD	3 Qtrs
Additions to patent, trademark and licensing rights	`PaymentsToAcquireIntangibleAssets`	$188.00K	USD	3 Qtrs
Deposits on capital leases refunded	`DepositsOnCapitalLeasesRefunded`	-	USD	3 Qtrs
Deposits on capital leases refunded	`DepositsOnCapitalLeasesRefunded`	$14.00K	USD	3 Qtrs
Sales and maturities of short-term and long-term marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$3.37M	USD	3 Qtrs
Sales and maturities of short-term and long-term marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$2.50M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$2.94M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$2.08M	USD	3 Qtrs
Payments on capital leases	`PaymentsOnCapitalLeases`	$19.00K	USD	3 Qtrs
Payments on capital leases	`PaymentsOnCapitalLeases`	$1.00K	USD	3 Qtrs
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$9.68M	USD	3 Qtrs
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$4.69M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$4.69M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$9.66M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$2.36M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-995.00K	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$4.47M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.12M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.16M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.16M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$4.47M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.12M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.16M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.16M	USD	Point-in-time
Issuance of common stock for accounts payable	`StockIssued1`	$672.00K	USD	3 Qtrs
Issuance of common stock for accounts payable	`StockIssued1`	-	USD	3 Qtrs
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnSecurities`	$-241.00K	USD	3 Qtrs
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnSecurities`	$112.00K	USD	3 Qtrs
Fair Value of redeemable warrants	`FairValueOfRedeemableWarrants`	$2.62M	USD	Point-in-time
Fair Value of redeemable warrants	`FairValueOfRedeemableWarrants`	-	USD	3 Qtrs
Fair Value of redeemable warrants	`FairValueOfRedeemableWarrants`	$2.62M	USD	3 Qtrs
Cash paid for interest expense	`InterestPaid`	$3.00K	USD	3 Qtrs
Cash paid for interest expense	`InterestPaid`	-	USD	3 Qtrs
Insurance proceeds from legal settlement	`InsuranceProceedsFromLegalSettlement`	$1.63M	USD	3 Qtrs
Insurance proceeds from legal settlement	`InsuranceProceedsFromLegalSettlement`	-	USD	3 Qtrs

Stockholders Equity 13 line items

Line Item	Tag	Value	Unit	Period
Balance, at beginning	`StockholdersEquity`	$20.37M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$16.63M	USD	Point-in-time
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$344.00K	USD	3 Qtrs
Shares sold at the market	`StockIssuedDuringPeriodValueNewIssues`	$174.00K	USD	3 Qtrs
Common stock issuance	`StockIssuedDuringPeriodValueNewIssues1`	$4.52M	USD	3 Qtrs
Other issuances	`StockIssuedDuringPeriodValueOther`	-	USD	3 Qtrs
Redeemable warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$2.62M	USD	3 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-12.33M	USD	3 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-6.16M	USD	3 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-2.88M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-4.02M	USD	1 Quarter
Balance, at end	`StockholdersEquity`	$20.37M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$16.63M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.